Aims. -To ascertain parameters that differentiate patients with HCM from athletes with moderate left ventricular (LV) hypertrophy (LVH 13-15 mm). Methods. -We retrospectively included 100 men: 50 elite rugby players (25 with moderate LVH and 25 with no LVH), 25 patients with HCM and moderate LVH and 25 controls. LV dyssynchrony was defined as the standard deviation of time to peak 2D longitudinal strain (16-segment model) and global strain components were computed from two-(2D) and three-dimensional (3D) speckle tracking.
Background
Differentiation between physiological and pathological left ventricular hypertrophy (LVH) is essential, as hypertrophic cardiomyopathy (HCM) is the main cause of sudden cardiac death in young athletes [1] [2] [3] . However, the diagnosis of HCM in athletes can be challenging because 1.5-8% of top-level athletes have moderate LVH (defined by a septal wall thickness of 13-15 mm) [4, 5] and some athletes with early stage HCM can excel in sport. Usually, clinical history, electrocardiogram (ECG) abnormalities and standard twodimensional (2D) echocardiography allow the identification of patients with HCM [6, 7] . However, cardiac remodelling and ECG features can vary widely depending on the sporting activity and the athlete's ethnicity. This explains the difficulty in differentiating an athlete's heart with moderate LVH from early stage HCM with conventional echocardiography and ECG. Recent studies have suggested that tissue Doppler imaging and 2D and three-dimensional (3D) speckle tracking-derived strain might be used to better characterize patients with HCM and the hearts of athletes [8] [9] [10] [11] [12] [13] . Strain analysis provides an accurate and reproducible assessment of longitudinal function and left ventricular (LV) dyssynchrony derived from strain curves [14] may be used to assess the consequence of myocardial disarray and hypertrophy on LV function. The purpose of the study was to examine the Please cite this article in press as: Ternacle LV dyssynchrony and GLS for differentiating physiological and pathological LVH 3 accuracy of 2D and 3D strain and LV dyssynchrony for differentiating athletes with moderate LVH (13-15 mm) from patients with HCM.
Methods

Subjects
This case-control study included 100 men: 25 competitive top-level athletes (rugby players) with moderate LVH (13-15 mm), 25 competitive top-level athletes (rugby players) without LVH, 25 patients with HCM and moderate LVH (13-15 mm) and 25 sedentary healthy subjects (control group). Top-level athletes were recruited from professional players of the Top 14 French National Rugby League. All athletes were screened annually by ECG and echocardiography and none had a history of cardiovascular disease. They had all undertaken endurance (running with interval training) as well as power (bodybuilding) training for > 10 hours/week for at least the past 8 months. The only specific criterion for the inclusion of athletes was septal thickness for athletes with moderate LVH.
HCM was defined by a wall thickness of ≥ 13 mm plus one of the following: a family history of HCM, a positive genetic screening or when a systolic anterior movement of the anterior mitral valve leaflet was present (with or without left ventricular outflow tract [LVOT] gradient). Patients with HCM were selected from our local cohort of patients with proven HCM without LVOT obstruction at rest before alcohol septal ablation or myomectomy. According to the Maron classification, 80% of patients with HCM were type 3, 12% were type 4 and 8% were type 2. Patients with atrial fibrillation, wide QRS duration (≥ 120 ms), an implanted pacemaker, with a suspected cause of HCM other than sarcomeric aetiology or with LV dysfunction (left ventricular ejection fraction [LVEF] ≤ 50%) were excluded.
The control group consisted of sedentary healthy subjects without a history of cardiac disease, with no specific criteria for inclusion. All subjects provided written informed consent and the study was approved by our local ethics committee.
Standard echocardiographic examination
Comprehensive 2D and 3D echocardiography was performed using a commercially available ultrasound system (Vivid 9, General Electrics, Horten, Norway). 2D echocardiography assessment included parasternal long-and short-axis views, apical 4-, 3-and 2-chamber views and conventional and tissue spectral Doppler imaging. LV, left atrial and aortic diameters were measured by M-mode from the parasternal long-axis view. Relative wall thickness (RWT) was defined as the sum of the septal and posterior wall thicknesses divided by the LV end-diastolic diameter. LV mass was determined using Devereux's formula. Ejection fraction and LV volumes were calculated using Simpson's biplane method. Pulsed mitral flow and tissue spectral Doppler imaging of the lateral and septal walls were used to assess diastolic function.
3D echocardiography assessment included an LV fullvolume acquisition using multi-beat modality (four cardiac cycles) from the apical view. LV volumes and LVEF were computed using semiautomated software (3D auto left ventricular quantification, EchoPAC, GE).
Speckle tracking and dyssynchrony measurements
2D and 3D strain components were computed from apical views using speckle-tracking analysis. The temporal resolutions for 2D and 3D data were 53 ± 3 and 22 ± 7 frames per cardiac cycle, respectively. Analysis was performed offline using dedicated 2D and 3D Echo-PAC software (GE, version 110.1.2). Automated function imaging for 2D imaging and auto left ventricular quantification for 3D imaging used a block-matching model to compute strain data. Endocardial delineation was obtained after manual positioning of the mitral valve plane and LV apex. The region of interest was adjusted manually to provide optimal wall tracking and segments that were inadequately tracked were discarded. For strain processing, the peak of the R wave was used as the end-diastolic reference point. 2D global longitudinal strain (GLS) was obtained by averaging the 16 regional longitudinal strain curves computed from the 2D apical views (4 C, 2 C, 3 C) and 3D GLS and circumferential strain components by averaging the 17 regional strain curves separately. 3D global radial and area strain components were derived by the software from longitudinal and circumferential curves. For better comprehensibility, all strain data are expressed as absolute values. LV dyssynchrony was defined as the standard deviation (16-segment model) (''2D-16SD'') of time to peak 2D longitudinal strain as previously described [14] . Time to peak strain was automatically computed using Excel from exported regional strain curves.
Statistical analysis
Continuous variables with a normal distribution are expressed as mean ± standard deviation (SD), those with a non-normal distribution as median (interquartile range [IQR] ). Dichotomous data are expressed as numbers and percentages. To compare numerical data between different groups, paired Student's t test, analysis of variance (ANOVA), Mann-Whitney and Kruskal-Wallis tests were used as appropriate. Nominal variables were compared using either the 2 or Fisher tests. Differentiation between athletes and patients with HCM was performed in the subgroup of subjects with septal or posterior wall thickness 13-15 mm. Receiver operator characteristic (ROC) analysis was performed to evaluate the ability of different echocardiographic parameters to identify patients with HCM and the area under the curve (AUC) expressed accuracy. During echocardiographic analysis in the subgroup of patients with moderate LVH, the investigator (CB) was blinded to the aetiology. Reproducibility of 2D and 3D GLS and LV dyssynchrony was performed in 10 random patients by an independent observer (JT). Reproducibility is expressed as the absolute difference and the absolute difference divided by the mean value (reported as a percentage). Two-tailed P-values < 0.05 were considered statistically significant.
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Results
Athletes were younger, taller and heavier than patients with HCM and controls (Table 1) . 2D speckle tracking was analysable in all subjects, but 9% of subjects had nonanalysable 3D strain (poor image quality).
Athletes versus controls
Athletes had larger indexed LV volumes and lower LVEF and tissue Doppler peak systolic myocardial velocities (lateral and septal wall) than control subjects (Table 1) . In contrast, all global strain components (2D and 3D) were similar, but athletes had greater LV dyssynchrony despite similar heart rates. Compared with the control group, athletes with moderate LVH had greater indexed wall thickness (6.2 ± 0.6 vs. 5.2 ± 0.7 mm; P = 0.0001) and lower tissue Doppler early diastolic velocity (septal and lateral wall). The number of subjects with LV end-diastolic diameter < 54 mm or < 51 mm was similar athletes with moderate LVH and controls (Table 1) . Interestingly, compared to athletes without LVH, those with moderate LVH were more likely to have a LV enddiastolic diameter < 54 mm or < 51 mm, had a higher RWT, a lower E/A ratio and lower 3D LVEF (Table 1) .
Patients with HCM versus athletes with moderate LVH
Indexed septal wall thickness > 7 mm/m 2 was observed in 12% (n = 3) of athletes with moderate LVH and in 24% of patients with HCM. Compared to athletes with moderate LVH, patients with HCM were more likely to have LV enddiastolic diameter < 51 mm with a concentric remodelling (RWT 0.54 ± 0.07 vs. 0.45 ± 0.05; P = 0.0001) and smaller 2D and 3D LV volumes (Table 1) . No difference was observed for left atrial diameter. Compared to athletes with moderate LVH, patients with HCM had a delayed relaxation pattern (E/A < 1) and a longer E wave deceleration time. Tissue Doppler imaging peak diastolic velocity (lateral and septal wall) was reduced and the E/e' ratio was increased in patients with HCM versus athletes with LVH. Despite a lower LVEF (2D and 3D) in athletes with LVH, 2D GLS and all 3D global strain components except for 3D global circumferential strain were better preserved in athletes with LVH than in patients with HCM (Table 1) . Interestingly, LV dyssynchrony was greater in patients with HCM than in athletes with LVH (66 ± 20 vs. 39 ± 8 ms; P = 0.0001).
Accuracy of single markers for identifying HCM
The accuracy of LV volumes and diastolic markers ranged between 0.68 and 0.86 ( Table 2 ). The highest accuracy was obtained with the septal and posterior wall thickness index (AUC = 0.86). The different threshold values of LV volumes and their related sensitivities and specificities for identifying patients with HCM are displayed in Table 3 .
For strain data, GLS accuracy was similar with 2D and 3D methods ( Table 2 and Fig. 1 ). The highest sum of sensitivity and specificity was obtained with an absolute longitudinal global strain > 18% for 2D GLS (Table 4) . However, the best accuracy was obtained using LV dyssynchrony (AUC = 0.92; Table 5 show that LV dyssynchrony > 48 ms identified HCM with 83% sensitivity and 89% specificity. Despite the absence of valvular disease, LV obstruction, symptoms, personal or familial previous cardiac disease and regular monitoring, intriguing results were observed in five athletes with moderate LVH. They were older (25-34 years), had e' lateral velocity < 10 cm/s and 3/5 had e' septal velocity < 8 cm/s (Supplementary data, Table S1 ), but the discrepancies between these echocardiographic parameters suggest that no single parameter can be used to identify physiological from pathological LVH.
Fig. 1). The different thresholds displayed in
Accuracy of combined markers for identifying HCM
Binary logistic regression showed that LV dyssynchrony and 2D GLS were independent predictors of HCM. Using the previously defined thresholds, only patients with HCM had Please cite this article in press as: Ternacle reduced GLS ≤ 18% and LV dyssynchrony > 48 ms, while none had preserved GLS without LV dyssynchrony (Fig. 2) .
Determinants of LV dyssynchrony in patients with HCM
In patients with HCM, LV dyssynchrony moderately correlated with posterior thickness (R = 0.46, P = 0.02), 2D GLS (R = −0.63, P < 0.001, Fig. 3 ) and tissue Doppler peak systolic velocity of the lateral wall (R = −0.45, P = 0.02). Better correlation was observed with diastolic markers-tissue Doppler early-peak diastolic velocity (R = −0.66, P < 0.001 for the septal wall and R = −0.52, P = 0.009 for the lateral wall, Fig. 4A ) and E/e' lateral ratio (R = 0.65, P < 0.001, Fig. 4B ).
No correlation was observed between LV dyssynchrony and 2D and 3D variables in athletes or controls.
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Reproducibility
Inter-observer variabilities were 4.2 ms (12.4%) for LV dyssynchrony, 0.7% (4.0%) for 2D GLS and 1.8% (10.0%) for 3D GLS.
Discussion
Differentiation between physiological and pathological LVH may be challenging in top-level athletes with moderate LVH in the grey zone (wall thickness 13-15 mm, Fig. 5 ).
Conventionally, HCM diagnosis relies on the combination of clinical history, ECG pattern and 2D echocardiography [6, 7] . However, LV physiological hypertrophy may be confounded with an early stage of HCM because echocardiographic and ECG parameters varies with patient ethnicity. In the present study, we demonstrated that LV dyssynchrony by 2D longitudinal strain best identified patients with HCM (AUC = 0.92) in the presence of moderate hypertrophy. Moderate LVH in athletes is typically associated with mild atrial and ventricular dilatation and limited LVEF reduction with normal septal/posterior wall ratio, RWT and diastolic function [4, 5] . In contrast, genetic HCM patients usually present specifically with asymmetrical septal hypertrophy and systolic anterior motion of the anterior mitral leaflet (with or without LVOT obstruction). Differentiation between adaptive LVH and advanced HCM is usually easy with conventional echocardiography parameters. However, early stage HCM echocardiography features may overlap with those of athletes with borderline LVH (13-15 mm) . A recent study by Caselli et al. addressed this issue by comparing 28 athletes matched to 25 patients with HCM with LVH 13-15 mm [15] . They reported 100% sensitivity and specificity for identifying patients with HCM when LV end-diastolic diameter was < 54 mm. However, in our study, LV end-diastolic diameter < 54 mm or < 51 mm [16] failed to accurately differentiate patients with HCM and athletes with LVH. We found better accuracy using end-systolic diameter and volume for identifying patients with HCM versus athletes with LVH in the grey zone of LVH. This discrepancy may be explained by differences in the athletes recruited, since Caselli et al. [15] Please cite this article in press as: Ternacle mostly included Olympic rowing, canoeing and cycling athletes that may develop more important LV dilatation and hypertrophy than rugby players.
Tissue Doppler imaging has been proposed for the characterization of HCM [17] systolic and diastolic myocardial dysfunction. Nagueh et al. demonstrated that tissue Doppler systolic myocardial velocities of the lateral mitral annulus (< 13 cm/s) identified HCM genotype-positive individuals without echocardiographic evidence of LVH from controls with a sensitivity of 100% and a specificity of 93% [18] . The accuracy of tissue Doppler imaging seems relevant for differentiating patients with HCM and control subjects, but the specificity is lower when comparing patients with HCM to athletes because of a physiological reduction of systolic myocardial velocities in athletes. Consistent with our data, Caselli et al. demonstrated that diastolic (but not systolic) tissue Doppler peak velocity differentiated patients with HCM from athletes with e' < 11.5 cm/s having 81% sensitivity and 61% specificity [15] . However, limitations of tissue Doppler imaging include the malalignment issue that only allows for the study of myocardial velocities in the basal and mid segments and the decrease in signal/noise ratio limiting its accuracy when longitudinal myocardial contraction is reduced.
These issues have been overcome by speckle tracking analysis, which uses grey-scale data for assessing myocardial deformation in the whole ventricle. Speckle tracking analysis using 2D and 3D imaging [9] has demonstrated that global strain components in athletes is homogenously [11] reduced but remain in the normal range (absolute GLS > 16%). In contrast, 2D longitudinal strain in patients with HCM is heterogeneously impaired, both in hypertrophied and non-hypertrophied segments before myocardial fibrosis is observed on cardiac magnetic resonance [12] . Recent studies have demonstrated that basal anteroseptal strain reduction is superior to tissue Doppler imaging for differentiating HCM genotype-positive individuals without echocardiographic evidence of LVH from controls [10] . Serri et al. showed that GLS was lower in patients with HCM compared to athletes and controls [19] . GLS impairment in HCM seems to increase the risk of heart failure, severe arrhythmia and death [20] [21] [22] . Our data demonstrated a similar accuracy of 2D and 3D GLS to identify patients with HCM when LVH was in the grey zone. However, despite high sensitivity (88%) for 2D GLS ≤18%, the specificity remains limited at 56% for differentiating patients with HCM and athletes with moderate LVH. In our study, we demonstrated that the specificity of 2D GLS reached 100% when combined with the presence of LV dyssynchrony.
Only one study has addressed LV dyssynchrony in athletes [23] , while dyssynchrony in HCM populations has only been reported in small studies [24, 25] . In the absence of conduction disturbance, myocardial contraction may be delayed in fibrotic, ischaemic or hypertrophic myocardium. Recoil movement is probably the main mechanism in fibrotic tissue, while stiffness and heterogeneous myocardium with fibre disarray causing abnormal cell-to-cell conduction and abnormal calcium handling may play a key role in hypertrophic segments. Schwammenthal et al. have demonstrated that myocardial contraction in hypertrophied regions ends in the early systolic phase, resulting in marked differences in LV contraction and relaxation time between hypertrophied and non-hypertrophied segments [25] . Consistent with these findings, we observed that LV dyssynchrony correlates with systolic and diastolic markers. D'Andrea et al. demonstrated that LV dyssynchrony increases the risk of sudden death [24] and Badran et al. suggested that LV dyssynchrony might be involved in the mechanism of QT interval prolongation in patients with HCM [26] . Our study demonstrated that LV dyssynchrony is a specific marker of HCM and should be combined with GLS measurement to obtain the best accuracy for identifying HCM in subjects with a grey zone LVH.
Limitations
Cardiac magnetic resonance imaging and genetic data are not reported because initial investigations of patients with HCM were not fully conducted in the same centre. Otherwise, we did not observe significant differences between patients with HCM and athletes for 3D global circumferential strain. Circumferential strain preservation may be a compensatory mechanism for maintaining LVEF. Interpretation of area and radial strain is more challenging since these strain components are indirectly computed from longitudinal and circumferential strain. These data should be interpreted with caution because of the limited validation of 3D measurements and cutoff values of GLS and dyssynchrony must be validated in an independent cohort. Finally, all acquisitions and analysis were performed on a GE system and results may not be transferrable to results using machines from other vendors.
Conclusions
Most conventional echocardiography methods can be used to differentiate patients with HCM and athletes with moderate LVH, but none of them had enough sensitivity or specificity to exclude HCM. We demonstrated that a preserved 2D longitudinal strain function and the absence of LV dyssynchrony can be used to exclude HCM, while abnormal longitudinal function associated with dyssynchrony is specific to HCM.
Sources of funding
The study received a grant from the French Federation of Cardiology. GE France provided the echocardiography system.
GE France generously provided the echocardiography system for scanning the athletes in the different sport centres, but was not involved in the data analysis or writing of the manuscript.
